CLINICAL CHARACTERISTICS AND QUALITY OF LIFE OF THAI MODERATE TO SEVERE PSORIASIS PATIENTS BEFORE INITIATING SECUKINUMAB: AN INTERIM ANALYSIS FROM PROMPT STUDY

被引：0
|
作者：
Wongpraparut, C. [1 ]
Tovanabutra, N. [2 ]
Laodheerasiri, S. [3 ]
Chakkavittumrong, P. [4 ]
Choonhakarn, C. [5 ]
Pattamadilok, B. [6 ]
Rattanakaemakorn, P. [7 ]
Sangob, N. [8 ]
Pongmesa, T. [9 ]
Asawanonda, P. [10 ]
机构：
[1] Siriraj Hosp, Bangkok, Thailand
[2] Chiang Mai Univ, Chiang Mai, Thailand
[3] Phramongkutklao Hosp, Bangkok, Thailand
[4] Thammasat Univ, Khlongluang, Pathum Tani, Thailand
[5] Khon Kaen Univ, Khon Kaen, Thailand
[6] Inst Dermatol, Bangkok, Thailand
[7] Ramathibodi Hosp, Bangkok, Thailand
[8] Novartis, Bangyai 12, Thailand
[9] Novartis, Bangkok, Thailand
[10] Chulalongkorn Univ, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO112
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [41] THE RELATIONSHIP BETWEEN DISEASE SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS
    Geale, K.
    Henriksson, M.
    Schmitt-Egenolf, M.
    VALUE IN HEALTH, 2015, 18 (07) : A675 - A675
  • [42] Ustekinumab improves quality of life in Japanese patients with moderate to severe plaque psoriasis
    Nakagawa, H.
    Kato, T.
    Kato, M.
    Igarashi, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 18 - 18
  • [43] A COST-PER-RESPONDER ANALYSIS OF SECUKINUMAB COMPARED WITH USTEKINUMAB IN SAUDI ARABIA: RESULTS FROM THE CLEAR STUDY OF PATIENTS WITH MODERATE TO SEVERE PSORIASIS
    Al Howimel, M.
    Al Jufan, K.
    AlAlwan, A.
    Alshehri, N.
    Al Mudaiheem, H.
    Al Amri, A.
    Al Hamdan, H.
    Zakaria, N.
    Al Kateb, L.
    Gilloteau, I
    Graham, C. N.
    Sekharan, M.
    VALUE IN HEALTH, 2018, 21 : S106 - S106
  • [44] Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study
    Mrowietz, U.
    Chouela, E. N.
    Mallbris, L.
    Stefanidis, D.
    Marino, V.
    Pedersen, R.
    Boggs, R. L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1114 - 1120
  • [45] Impact of moderate-to-severe psoriasis on quality of life in China: a qualitative study
    Hua Zhong
    Huan Yang
    Zhuxin Mao
    Xiaoyun Chai
    Shunping Li
    Health and Quality of Life Outcomes, 19
  • [46] Impact of moderate-to-severe psoriasis on quality of life in China: a qualitative study
    Zhong, Hua
    Yang, Huan
    Mao, Zhuxin
    Chai, Xiaoyun
    Li, Shunping
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [47] Rasch analysis of the dermatology life quality index (DLQI) in patients with mild to moderate-severe psoriasis
    Madrigal-Cadavid, Juliana
    Estrada-Acevedo, Jorge
    Jaramillo, Ana Maria
    Jaramillo-Santacoloma, Laura
    Guarin, Simon
    Londono, Angela
    Rojas-Gualdron, Diego
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (04): : 433 - 439
  • [48] QUALITY OF LIFE (QOL) WITH PSORIASIS: ETHNOGRAPHY STUDY EVALUATING THE IMPACT OF PSORIASIS ON MODERATE TO SEVERE PATIENTS IN EUROPE (EU), FROM A PATIENT'S PERSPECTIVE
    Narayanan, S.
    Franceschetti, A.
    VALUE IN HEALTH, 2014, 17 (07) : A538 - A538
  • [49] Clinical outcomes and quality of life in a cross-sectional study of patients with moderate-to-severe psoriasis treated with bimekizumab in routine clinical practice
    Wicker, Gemma
    Tredwell, Amanda
    Topliffe, Joanne
    Smith, Maureen
    Vistenia, Jason
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I66 - I66
  • [50] Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
    Bhatia, Neal
    Heim, Jayme
    Schenkel, Brad
    Vasquez, J. Gabriel
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
12345